Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase I/II |
| Species: | Human |
| Stage: | Primary analysis complete |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A Phase I/II clinical trial to evaluate the safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and ALVAC HIV prime / LIPO-5 boost in healthy, HIV-1 uninfected adult participants
Description
HVTN 042 is a Phase I/II clinical trial to evaluate the safety and immunogenicity of LIPO-5 alone, ALVAC-HIV (vCP1452) alone, and a ALVAC HIV prime / LIPO-5 boost.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.